Philadelphia, Pennsylvania 19104


Purpose:

The purpose of this study is to determine what happens to dexmedetomidine in the body after it has been given to a newborn after heart surgery. We want to learn how long the drug stays in the body, how the drug is metabolized by the body, and how well the medicine works at a particular dose or amount.


Study summary:

This is a single center, dose escalation study of a single bolus dose of dexmedetomidine followed by a continuous infusion for up to 24 hours in neonates who are immediately post-op from cardiac surgery, and require tracheal intubation with mechanical ventilation in the post-op period. Pediatric populations may benefit from the favorable pharmacodynamic effects of this medication.


Criteria:

Inclusion Criteria: - Patients must be less than or equal to 1 month old. - Postconceptual age must be > or equal to 37 weeks on the day of surgery. - Postoperative from cardiac surgery with tracheal intubation/mechanical ventilation in the immediate post-op period. - Planned tracheal extubation within 24 hrs post-op. - Adequate reanl function (serum creatine < or equal to 1.5mg/dL) - Adequate liver function (ALT < or equal to 165 U/L) - Isolated heart surgery - Informed consent Exclusion Criteria: - Patients who have received another investigational drug since birth. - Patients receiving continuous infusions of muscle relaxants in the post-op setting. - Pateints who have a positive blood culture without a subsequent negative culture of other evidence of ongoing serious infection. - Patients who show signs and symptoms of elevated intracranial pressure. - Post-op hypotension defined by post conceptual age. - Pre-existing bradycardia defined by age - Heart block - Weight < 2kg - Patients who, in the opinion of the investigator, are not appropriate candidates for an investigational drug study


NCT ID:

NCT00576381


Primary Contact:

Principal Investigator
Felice Su, MD
Children's Hospital of Philadelphia

Felice Su, MD
Phone: 2155901000
Email: su@email.chop.edu


Backup Contact:

Email: zuppa@email.chop.edu
Athena Zuppa, MD, MSCE


Location Contact:

Philadelphia, Pennsylvania 19104
United States

Mary Ann DiLiberto, BS, RN
Phone: 267-426-5753
Email: diliberto@email.chop.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 24, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.